Report Information More information from: https://www.wiseguyreports.com/reports/1236445
Global Swine Health Market 2017-2021 Report / Search Code: WGR1236445
Price
1-user PDF : $ 3500.0
Description:
Publish Date: 26 April, 2017
1-5 User PDF : $ 4000.0
Enterprise PDF : $ 10000.0
Swine Health The global swine health market is expected to benefit from the increasing incidence of disease through swine. The disease is associated with an increased cost burden in many developed and developing economies. As the demand for livestock is increasing, end-users are increasingly opting for antibiotics and vaccines. Also, vendors are extensively conducting R&D activities to develop novel therapeutics to address unmet medical needs. Technavio’s analysts forecast the global swine health market to grow at a CAGR of 7.82% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global swine health market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of swine health. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Swine Health Market 2017-2021, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Boehringer Ingelheim • Ceva Santé Animale • Elanco • Merck Animal Health • Zoetis Other prominent vendors • Animal Medics • Biogénesis Bagó • Biovet • Dechra • ECO Animal Health • Huvepharma • Indian Immunologicals • Lillidale Animal Health • Mobedco-Vet (The Arab Pesticides & Veterinary Drugs) • Neogen • Norbrook • Orion • Phibro Animal Health • Vétoquinol • Virbac • Vitafor Market driver • Increase in pork farming in China • For a full, detailed list, view our report Market challenge • Increase in antibiotic resistance in bacteria • For a full, detailed list, view our report
Market trend • Increase in antibiotic resistance in bacteria • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Contents:
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Major diseases • Aujeszky's disease (AD) • Classical swine fever (CSF) • Actinobacillus pleuropneumonia • Mycoplasma hyopneumoniae • Swine enteric coronavirus disease • Porcine reproductive and respiratory syndrome (PRRS) • Salmonella PART 06: Market landscape • Market overview • Five forces analysis PART 07: Swine health diagnostics • Overview • Market dynamics PART 08: Market segmentation by route of administration (ROA) • Injectables • Oral PART 09: Market segmentation by product category • Antibiotics • Vaccines • Others PART 10: Geographical segmentation • Swine health market in Americas • Swine health market in EMEA • Swine health market in APAC PART 11: Decision framework PART 12: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 13: Market trends • Increase in use of water-soluble organic feed additives • Demand for veterinary specialists • Industry-academia collaborations PART 14: Vendor landscape • Competitive scenario PART 15: Key vendor analysis • Boehringer Ingelheim • Ceva Santé Animale • Elanco • Merck Animal Health • Zoetis • Other prominent vendors PART 16: Appendix • List of abbreviations List of Exhibits
Exhibit 01: Global swine health market Exhibit 02: Global swine health market 2016-2021 ($ millions) Exhibit 03: Opportunity analysis in global swine health market Exhibit 04: Five forces analysis Exhibit 05: The diagnostic tests based on disease type Exhibit 06: Swine health diagnostics: Drivers and challenges Exhibit 07: Market segmentation by ROA 2016 Exhibit 08: Market segmentation by product category 2016 Exhibit 09: Global antibiotics segment in swine health market 2016-2021 ($ millions) Exhibit 10: Global vaccines segment in swine health market 2016-2021 ($ millions) Exhibit 11: Global others segment in swine health market 2016-2021 ($ millions) Exhibit 12: Segmentation of global swine health market based on geography 2016 and 2021 Exhibit 13: Global swine health market revenue by geography 2016-2021 ($ millions) Exhibit 14: Market scenario in Americas Exhibit 15: Swine health market in Americas 2016-2021 ($ millions) Exhibit 16: Market scenario in EMEA Exhibit 17: Swine health market in EMEA 2016-2021 ($ millions) Exhibit 18: Market scenario in APAC Exhibit 19: Swine health market in APAC 2016-2021 ($ millions) Exhibit 20: China meat consumption in 2013 Exhibit 21: Global growth in demand for livestock products 2000- 2030 (thousands of metric tons) Exhibit 22: Impact of drivers Exhibit 23: Impact of challenges Exhibit 24: Competitive structure analysis of global swine health market 2016 Exhibit 25: Boehringer Ingelheim: Key highlights Exhibit 26: Boehringer Ingelheim: Strength assessment Exhibit 27: Boehringer Ingelheim: Strategy assessment Exhibit 28: Boehringer Ingelheim: Opportunity assessment Exhibit 29: Ceva Santé Animale: Key highlights Exhibit 30: Ceva Santé Animale: Strength assessment Exhibit 31: Ceva Santé Animale: Strategy assessment Exhibit 32: Ceva Santé Animale: Opportunity assessment Exhibit 33: Elanco: Key highlights Exhibit 34: Elanco: Strength assessment Exhibit 35: Elanco: Strategy assessment Exhibit 36: Elanco: Opportunity assessment Exhibit 37: Merck Animal Health: Key highlights Exhibit 38: Merck Animal Health: Strength assessment Exhibit 39: Merck Animal Health: Strategy assessment Exhibit 40: Merck Animal Health: Opportunity assessment Exhibit 41: Zoetis: Key highlights Exhibit 42: Zoetis: Strength assessment Exhibit 43: Zoetis: Strategy assessment Exhibit 44: Zoetis: Opportunity assessment
wiseguyreports.com / Phone (US) + 1-646-845-9349 (UK) +44 208 133 9349